학술논문

Progression of pulmonary veno‐occlusive disease without pulmonary hypertension
Document Type
article
Source
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Subject
drug toxicity
pulmonary hypertension
pulmonary veno‐occlusive disease
Diseases of the circulatory (Cardiovascular) system
RC666-701
Diseases of the respiratory system
RC705-779
Language
English
ISSN
2045-8940
Abstract
Abstract Pulmonary veno‐occlusive disease (PVOD) is a progressively fatal disease with no definitive treatment options. PVOD can be a result of genetic mutation but can also be due secondary to exposure to solvents or chemotherapeutic agents. Generally, at the time of diagnosis PVOD is associated with hemodynamically confirmed pulmonary hypertension (PH). In this study, we describe a patient who was diagnosed with PVOD early in the disease without hemodynamically confirmed PH. She had histologically confirmed PVOD. Her clinical presentation posed management challenges and prednisone therapy was used to stabilize her disease. This case and some recently published reports highlight possible immune dysregulation in PVOD and role for immuno‐suppressive therapy in these patients.